Capital Performance Advisors »

Phathom Pharmaceuticals shares owned by Capital Performance Advisors

Quarter-by-quarter ownership of Phathom Pharmaceuticals (PHAT) shares owned by Capital Performance Advisors from 13F filings

Historical chart of Capital Performance Advisors investment in Phathom Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Phathom Pharmaceuticals held by Capital Performance Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Phathom Pharmaceuticals by Capital Performance Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $524 29 18.07

More positions owned by Capital Performance Advisors

Dimensional Etf Trust Us Core Equity 2 (DFAC)
Dimensional Etf Trust Us Targeted Vlu (DFAT)
Dimensional Etf Trust Us Mktwide Value (DFUV)
Dimensional Etf Trust Internatnal Val (DFIV)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Dimensional Etf Trust Us Equity Market (DFUS)
Dimensional Etf Trust Us Small Cap Etf (DFAS)
Microsoft Corporation (MSFT)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Specialized Funds Div App Etf (VIG)
Dimensional Etf Trust World Ex Us Core (DFAX)
Amazon (AMZN)

View all positions for Capital Performance Advisors

Top funds holding Phathom Pharmaceuticals

Frazier Life Sciences Management
Medicxi Ventures Management
Jennison Associates
Invesco
Carlyle
BlackRock
BlackRock
Ensign Peak Advisors
Woodline Partners
Vanguard Group
NEA Management Company
Avidity Partners Management
OrbiMed Advisors
Federated Investors
Decheng Capital

View all funds holding Phathom Pharmaceuticals